BBIO BridgeBio Pharma, Inc. - Common Stock
$84.70
가격 · 8월 19, 2026
기준 재무 정보 8월 10, 2026
52주 범위
$47–$93
81% of range
애널리스트 평점
BUY
28 analysts
목표 주가
$108
+28% upside
P/E (TTM)
-22.5
ROE
41.2%
순이익률
-146.0%
BBIO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$84.70
시가총액
$16.58B
P/E (TTM)
-22.5
EPS (TTM)
$-3.78
매출 (TTM)
$502M
배당 수익률
—
ROE
41.2%
부채/자본
—
52주 범위
$47 – $93
BBIO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$502M
2019-12-31
→
2025-12-31
EPS
$-3.78
2020-12-31
→
2025-12-31
잉여현금흐름
$-447M
2019-12-31
→
2025-12-31
마진
-146.0%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
BBIO
동종업계 중앙값
P/E (TTM)
-22.5
28.5
P/S (TTM)
33.0
20.1
P/B
-7.9
12.9
Price / FCF (주가 / FCF)
-37.1
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
BBIO
동종업계 중앙값
Operating Margin (영업이익률)
-104.2%
—
Net Profit Margin (순이익률)
-146.0%
-48.4%
ROA
-79.0%
-28.4%
ROE
41.2%
-49.2%
ROIC
25.1%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
BBIO
동종업계 중앙값
Current Ratio (유동비율)
2.8
5.0
Quick Ratio (당좌 비율)
2.5
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
BBIO
동종업계 중앙값
Revenue YoY (매출 YoY)
126.3%
—
Revenue CAGR 3Y (매출 CAGR 3년)
86.3%
—
Revenue CAGR 5Y (매출 CAGR 5년)
127.4%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
BBIO
동종업계 중앙값
BBIO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
28 명의 애널리스트
- 적극 매수 6 21.4%
- 매수 19 67.9%
- 보유 3 10.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
21 명의 애널리스트 · 2026-08-16
중앙값
$108.00
지금
$84.70
저가
$80.00
고가
$157.00
중앙값 목표
$108.00
+27.5%
평균 목표
$108.43
+28.0%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.11%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.78 | $-0.60 | -0.18% |
| 2026년 3월 31일 | $-0.84 | $-0.69 | -0.15% |
| 2025년 12월 31일 | $-1.00 | $-0.76 | -0.24% |
| 2025년 9월 30일 | $-0.95 | $-0.91 | -0.04% |
| 2025년 6월 30일 | $-0.95 | $-0.86 | -0.09% |
| 2025년 3월 31일 | $-0.88 | $-0.94 | 0.06% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Cost of Revenue | $21M | $4M | $2M | $3M | $3M | · | · | |
| R&D Expense | $452M | $506M | $456M | $399M | $451M | $337M | $210M | |
| SG&A Expense | $531M | $289M | $151M | $143M | $192M | $146M | $94M | |
| Operating Expenses | $1.03B | $815M | $617M | $590M | $646M | $483M | $307M | |
| Operating Income | $-523M | $-593M | $-607M | $-512M | $-577M | $-474M | $-266M | |
| Interest Expense | · | · | $81M | $80M | $47M | $37M | $9M | |
| Interest Income | $20M | $17M | $18M | $8M | $1M | $4M | $9M | |
| Other Non-op | $43M | $12M | $17M | $-8M | $36M | $2M | $-2M | |
| Pretax Income | $-733M | $-542M | $-653M | $-485M | · | $505M | $289M | |
| Income Tax | $435.0K | $1M | $0 | $0 | · | · | · | |
| Net Income | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| EPS (Basic) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| EPS (Diluted) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| Shares (Basic) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| Shares (Diluted) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| EBITDA | $-518M | $-587M | $-601M | $-505M | $-571M | $-474M | $-266M |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $570M | $681M | $376M | $377M | $394M | $356M | $364M | |
| Short-term Investments | · | $0 | $0 | $52M | $394M | $251M | $182M | |
| Receivables | $139M | $5M | $2M | · | · | · | · | |
| Inventory | $27M | $0 | · | · | · | · | · | |
| Prepaid Expense | $44M | $35M | $24M | $22M | $32M | $36M | $20M | |
| Current Assets | $798M | $721M | $478M | $549M | $889M | $643M | $569M | |
| PP&E (Net) | $5M | $7M | $12M | $15M | $30M | $20M | $6M | |
| Intangibles | $28M | $24M | $26M | $29M | $45M | $0 | · | |
| Other Non-current Assets | $17M | $18M | $23M | $20M | $33M | $24M | $26M | |
| Total Assets | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Accounts Payable | $36M | $10M | $11M | $12M | $12M | $9M | $9M | |
| Accrued Liabilities | · | · | · | · | · | · | $3M | |
| Current Liabilities | $288M | $154M | $144M | $121M | $135M | $96M | $60M | |
| Capital Leases | $4M | $5M | $9M | $12M | $17M | $15M | · | |
| Other Non-current Liabilities | $244.0K | $286.0K | $6M | $27M | $22M | $10M | $4M | |
| Total Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $596M | $156M | |
| Long-term Debt | $2.01B | · | · | · | · | $94M | $95M | |
| Total Debt | · | $437M | $446M | $431M | $431M | $94M | $92M | |
| Common Stock | $202.0K | $196.0K | $181.0K | $157.0K | $154.0K | $125.0K | $124.0K | |
| Paid-in Capital | $2.06B | $1.90B | · | · | · | · | · | |
| Retained Earnings | $-3.82B | $-3.10B | $-2.56B | $-1.92B | $-1.44B | $-889M | $-440M | |
| Treasury Stock | $323M | $275M | $275M | $275M | $275M | $75M | · | |
| AOCI | $12.0K | $8.0K | $31.0K | $-328.0K | $-132.0K | $192.0K | $254.0K | |
| Stockholders' Equity | $-2.09B | $-1.47B | $-1.35B | $-1.25B | $-870M | $58M | $408M | |
| Liabilities + Equity | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Shares Outstanding | 194,771,957 | 190,044,473 | 175,082,951 | 150,625,572 | 147,343,323 | 122,849,389 | 123,658,287 |
현금 흐름 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $6M | $6M | $7M | $6M | $1M | $859.0K | |
| Stock-based Comp | $133M | $96M | $109M | $92M | $100M | $58M | $21M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Amort. of Intangibles | $3M | $2M | $2M | $2M | $3M | · | · | |
| Restructuring | · | $16M | $8M | $44M | $0 | $0 | · | |
| Other Non-cash | $149M | $-79M | $10M | $-33M | $-17M | · | · | |
| Operating Cash Flow | $-446M | $-521M | $-528M | $-419M | $-498M | $-400M | $-254M | |
| CapEx | $1M | $933.0K | $1M | $5M | $13M | $8M | $3M | |
| Investing Cash Flow | $-24M | $61M | $54M | $453M | $-201M | $-53M | $-217M | |
| Net Debt Issued | · | $-473M | $0 | $-20M | $-124M | · | · | |
| Stock Issued | $0 | $315M | $450M | $5M | $0 | $0 | · | |
| Stock Repurchased | $48M | $0 | $0 | $0 | $200M | $75M | · | |
| Net Stock Activity | $-48M | $315M | $144M | $5M | $-200M | $-75M | · | |
| Dividends Paid | · | · | · | · | · | · | $997.0K | |
| Financing Cash Flow | $359M | $748M | $452M | $-13M | $736M | $447M | $399M | |
| Net Change in Cash | $-111M | $289M | $-22M | $21M | $38M | $-6M | $-72M | |
| Taxes Paid | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | $-447M | $-522M | $-529M | $-424M | $-511M | $-407M | $-256M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% | -5752.0% | -656.4% | |
| Net Margin | -146.0% | -244.9% | -7021.9% | -624.2% | -841.2% | -6127.9% | -711.5% | |
| Pretax Margin | -145.9% | -244.3% | · | · | · | 6127.9% | 711.5% | |
| EBITDA Margin | -103.2% | -264.5% | -6458.9% | -650.9% | -818.7% | -5752.0% | -656.4% | |
| ROA | -79.0% | -74.1% | -111.7% | -59.2% | -68.3% | -75.7% | -52.6% | |
| ROE | 41.2% | 38.5% | 50.1% | 45.6% | 144.4% | -216.8% | -101.0% | |
| ROIC | 25.1% | 57.7% | · | · | · | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 | 6.7 | 9.4 | |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 | 6.3 | 9.0 | |
| Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| LT Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| Interest Coverage | · | · | -7.5 | -6.4 | -12.3 | -12.9 | -30.4 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Inventory Turnover | 1.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.0 | 68.6 | · | · | · | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 126.3% | 2285.3% | -88.0% | 11.4% | 745.1% | · | · | |
| Revenue CAGR 3Y | 86.3% | 47.1% | 4.1% | · | · | · | · | |
| Revenue CAGR 5Y | 127.4% | · | · | · | · | · | · |
가치 평가 (TTM) 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Net Income TTM | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| Market Cap | $14.90B | $5.21B | $7.07B | $1.15B | $2.46B | $8.74B | $4.33B | |
| Enterprise Value | · | $4.97B | $7.14B | $1.15B | $2.10B | $8.22B | $3.88B | |
| P/E | -20.2 | -9.5 | -10.2 | -2.3 | -4.3 | -18.7 | · | |
| P/S | 29.7 | 23.5 | 759.8 | 14.8 | 35.3 | 1059.0 | 106.9 | |
| P/B | -7.1 | -3.6 | -5.2 | -0.9 | -2.8 | 150.9 | 10.6 | |
| P / Tangible Book | · | · | · | · | · | 150.9 | · | |
| P / Cash Flow | -33.4 | -10.0 | -13.4 | -2.7 | -4.9 | -21.9 | -17.1 | |
| P / FCF | -33.3 | -10.0 | -13.4 | -2.7 | -4.8 | -21.5 | -16.9 | |
| EV / EBITDA | · | -8.5 | -11.9 | -2.3 | -3.7 | -17.3 | -14.6 | |
| EV / FCF | · | -9.5 | -13.5 | -2.7 | -4.1 | -20.2 | -15.1 | |
| EV / Revenue | · | 22.4 | 767.3 | 14.8 | 30.1 | 996.8 | 95.7 | |
| Dividend Yield | · | · | · | · | · | · | 0.02% | |
| Earnings Yield | -4.9% | -10.5% | -9.8% | -42.8% | -23.4% | -5.3% | · | |
| Payout Ratio | · | · | · | · | · | · | -0.35% | |
| Annual Payout | · | · | · | · | · | · | $997.0K |
손익계산서 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $195M | $154M | $121M | $111M | $117M | $6M | $3M | $2M | $211M | $2M | $4M | $2M | $2M | $2M | $338.0K | |
| Cost of Revenue | $15M | $10M | $8M | $7M | $4M | $3M | $2M | $598.0K | $598.0K | $598.0K | $598.0K | $598.0K | $599.0K | $651.0K | $647.0K | $739.0K | |
| R&D Expense | $149M | $127M | $116M | $113M | $111M | $111M | $130M | $120M | $115M | $141M | $130M | $125M | $107M | $93M | $91M | $93M | |
| SG&A Expense | $186M | $164M | $158M | $138M | $129M | $106M | $95M | $69M | $60M | $66M | $48M | $36M | $36M | $31M | $32M | $31M | |
| Operating Expenses | $351M | $300M | $294M | $266M | $245M | $221M | $232M | $194M | $178M | $211M | $179M | $162M | $148M | $128M | $131M | $129M | |
| Operating Income | $-107M | $-106M | $-140M | $-145M | $-134M | $-104M | $-226M | $-192M | $-176M | $343.0K | $-177M | $-158M | $-146M | $-126M | $-129M | $-129M | |
| Interest Expense | · | · | · | · | · | · | · | · | $23M | $23M | · | $20M | $21M | $20M | · | $20M | |
| Interest Income | $7M | $6M | $4M | $6M | $4M | $5M | $5M | $3M | $5M | $4M | $6M | $4M | $5M | $4M | $4M | $2M | |
| Other Non-op | $6M | $4M | $12M | $16M | $7M | $8M | $2M | $2M | $-632.0K | $9M | $22M | $-5M | $1M | $-601.0K | $5M | $6M | |
| Pretax Income | $-156M | · | $-195M | $-186M | $-182M | · | $-266M | $-164M | $-76M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-120.0K | $-2M | $2M | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-156M | $-167M | $-195M | $-185M | $-184M | $-170M | $-267M | $-164M | $-76M | $-36M | $-170M | $-179M | $-161M | $-143M | $-141M | $-140M | |
| EPS (Basic) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| EPS (Diluted) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| Shares (Basic) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| Shares (Diluted) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| EBITDA | $-107M | $-105M | · | $-145M | $-134M | $-103M | · | $-192M | $-176M | $2M | · | $-158M | $-146M | $-125M | · | $-129M |
대차대조표 25
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $678M | $880M | $570M | $643M | $749M | $541M | $681M | $266M | $408M | $475M | $376M | $505M | $302M | $407M | $377M | $483M | |
| Short-term Investments | · | · | · | · | $8M | · | · | · | $40M | $44M | · | $0 | $31M | $34M | · | $75M | |
| Receivables | $254M | $205M | $139M | $117M | $77M | $115M | $5M | · | · | · | · | · | · | · | · | · | |
| Inventory | $53M | $33M | $27M | $25M | $18M | $4M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $66M | $63M | $44M | $52M | $60M | $35M | $35M | $38M | $28M | $28M | · | $23M | $21M | $25M | · | $26M | |
| Current Assets | $1.09B | $1.24B | $798M | $839M | $912M | $695M | $721M | $445M | $616M | $783M | · | $588M | $433M | $553M | · | $642M | |
| PP&E (Net) | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $10M | $11M | · | $12M | $13M | $14M | · | $16M | |
| Intangibles | $27M | $27M | $28M | $29M | $30M | $28M | $24M | $25M | $25M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Other Non-current Assets | $20M | $19M | $17M | $26M | $18M | $17M | $18M | $20M | $19M | $21M | · | $19M | $20M | $21M | · | $30M | |
| Total Assets | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Accounts Payable | $27M | $29M | $36M | $19M | $26M | $28M | $10M | $13M | $18M | $5M | · | $4M | $4M | $4M | · | $10M | |
| Current Liabilities | $891M | $816M | $288M | $217M | $176M | $152M | $154M | $139M | $134M | $141M | · | $106M | $110M | $97M | · | $119M | |
| Capital Leases | $15M | $14M | $4M | $3M | $4M | $5M | $5M | $6M | $7M | $8M | · | $10M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | $240.0K | $229.0K | $244.0K | $679.0K | $545.0K | $352.0K | $286.0K | $377.0K | $485.0K | $595.0K | · | $12M | $13M | $18M | · | $28M | |
| Total Liabilities | $3.72B | $3.64B | $3.01B | $2.92B | $2.86B | $2.52B | $2.38B | $1.88B | $1.88B | $1.89B | · | $1.85B | $1.85B | $1.84B | · | $1.86B | |
| Long-term Debt | $2.65B | $2.65B | $2.01B | $2.01B | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | $0 | · | $436M | $435M | $435M | · | $442M | $440M | $436M | · | · | |
| Common Stock | $206.0K | $204.0K | $202.0K | $200.0K | $198.0K | $197.0K | $196.0K | $195.0K | $194.0K | $193.0K | · | $180.0K | $168.0K | $167.0K | · | $156.0K | |
| Paid-in Capital | $2.16B | $2.11B | $2.06B | $2.02B | · | · | $1.90B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-4.14B | $-3.99B | $-3.82B | $-3.63B | $-3.45B | $-3.26B | $-3.10B | $-2.83B | $-2.67B | $-2.60B | · | $-2.39B | $-2.22B | $-2.06B | · | $-1.78B | |
| Treasury Stock | $533M | $406M | $323M | $323M | $323M | $323M | $275M | $275M | $275M | $275M | · | $275M | $275M | $275M | · | $275M | |
| AOCI | $-7.0K | $-8.0K | $12.0K | $2.0K | $1.0K | $0 | $8.0K | $5.0K | $-4.0K | $2.0K | · | $34.0K | $63.0K | $-12.0K | · | $-348.0K | |
| Stockholders' Equity | $-2.52B | $-2.28B | $-2.09B | $-1.93B | $-1.79B | $-1.65B | $-1.47B | $-1.23B | $-1.09B | $-1.05B | · | $-1.21B | $-1.36B | $-1.23B | · | $-1.14B | |
| Liabilities + Equity | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Shares Outstanding | 195,284,352 | 195,707,702 | 194,771,957 | 192,633,286 | 191,162,659 | 189,826,023 | 190,044,473 | 188,986,547 | 188,032,738 | 187,122,744 | 175,082,951 | 174,131,954 | 161,419,931 | 160,435,238 | · | 149,367,087 |
현금 흐름 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $44M | $33M | $35M | $35M | $37M | $26M | $30M | $27M | $21M | $17M | $37M | $23M | $27M | $22M | $22M | $17M | |
| Amort. of Intangibles | $700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $300.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | $3M | $3M | · | $272.0K | $4M | $3M | $8M | $5M | |
| Other Non-cash | · | $-65M | · | · | · | $-57M | · | · | · | $-202M | · | · | · | $-25M | · | · | |
| Operating Cash Flow | $-71M | $-197M | $-56M | $-110M | $-81M | $-199M | $-195M | $-181M | $75M | $-220M | $-125M | $-145M | $-113M | $-144M | $-93M | $-135M | |
| CapEx | $443.0K | $69.0K | $33.0K | $470.0K | $594.0K | $0 | $47.0K | $137.0K | $54.0K | $695.0K | $435.0K | $431.0K | $428.0K | $12.0K | $801.0K | $759.0K | |
| Investing Cash Flow | $18M | $-43M | $-14M | $4M | $-13M | $-2M | $-3M | $38M | $3M | $23M | $-66.0K | $38M | $4M | $12M | $18M | $147M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $450M | · | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $-459M | · | · | · | $-23M | · | · | · | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-18.0K | $-495.0K | $315M | $-454.0K | $306M | $1M | $143M | $5M | $0 | |
| Stock Repurchased | $128M | $82M | $0 | $0 | $0 | $48M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $-82M | · | · | · | $-48M | · | · | · | $315M | · | · | · | $143M | · | · | |
| Financing Cash Flow | $-149M | $550M | $-2M | $-894.0K | $302M | $60M | $474M | $707.0K | $-6M | $280M | $-5M | $307M | $-1M | $150M | $6M | $1M | |
| Net Change in Cash | $-202M | $310M | $-73M | $-106M | $208M | $-141M | $275M | $-142M | $72M | $83M | $-129M | $199M | $-110M | $18M | $-69M | $13M | |
| Free Cash Flow | · | $-197M | · | · | · | $-199M | · | · | · | $-220M | · | · | · | $-144M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -43.9% | -54.5% | · | -120.3% | -121.4% | -89.5% | · | -7018.7% | -8096.8% | 0.16% | · | -3854.6% | -8903.1% | -6909.3% | · | -38200.0% | |
| Net Margin | -64.0% | -85.6% | · | -153.2% | -166.2% | -145.4% | · | -6012.2% | -3484.5% | -17.1% | · | -4387.4% | -9793.0% | -7816.6% | · | -41477.2% | |
| Pretax Margin | -64.0% | · | · | -154.5% | -164.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -53.9% | · | -120.3% | -121.4% | -88.4% | · | -7018.7% | -8096.8% | 0.92% | · | -3854.6% | -8903.1% | -6819.8% | · | -38200.0% | |
| ROA | -13.6% | -14.8% | · | -22.2% | -19.6% | -19.6% | · | -24.9% | -11.6% | -4.9% | · | -25.9% | -23.5% | -19.8% | · | -18.6% | |
| ROE | 7.2% | 8.5% | · | 11.7% | 12.8% | 12.6% | · | 13.5% | 6.2% | 3.2% | · | 15.3% | 13.5% | 12.6% | · | 14.9% | |
| ROIC | 4.3% | · | · | 7.4% | 7.6% | · | · | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.5 | · | 3.9 | 5.2 | 4.6 | · | 3.2 | 4.6 | 5.5 | · | 5.5 | 3.9 | 5.7 | · | 5.4 | |
| Quick Ratio | 1.0 | 1.3 | · | 3.5 | 4.7 | 4.3 | · | 1.9 | 3.3 | 3.7 | · | 4.8 | 3.0 | 4.6 | · | 4.7 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -7.7 | 0.0 | · | -7.8 | -7.1 | -6.3 | · | -6.5 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 1.2 | · | 2.1 | 2.8 | 2.0 | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $669M | $542M | · | $351M | $232M | $333M | · | $220M | $219M | $219M | · | $8M | $78M | $78M | · | $78M | |
| Net Income TTM | $-691M | $-705M | · | $-703M | $-593M | $-446M | · | $-455M | $-452M | $-519M | · | $-623M | $-446M | $-487M | · | $-505M | |
| Market Cap | $14.54B | $14.53B | · | $10.01B | $8.25B | $6.56B | · | $4.81B | $4.76B | $5.79B | · | $4.59B | $2.78B | $2.66B | · | $1.48B | |
| Enterprise Value | · | · | · | · | $7.50B | $6.02B | · | $4.98B | $4.75B | $5.70B | · | $4.53B | $2.88B | $2.65B | · | · | |
| P/E | -21.2 | -20.5 | · | -14.3 | -14.0 | -14.8 | · | -10.1 | -9.6 | -9.7 | · | -6.7 | -5.9 | -5.1 | · | -2.9 | |
| P/S | 21.7 | 26.8 | · | 28.5 | 35.6 | 19.7 | · | 21.9 | 21.7 | 26.5 | · | 581.5 | 35.8 | 34.3 | · | 19.0 | |
| P/B | -5.8 | -6.4 | · | -5.2 | -4.6 | -4.0 | · | -3.9 | -4.4 | -5.5 | · | -3.8 | -2.0 | -2.2 | · | -1.3 | |
| P / Cash Flow | · | -73.7 | · | · | · | -32.9 | · | · | · | -26.4 | · | · | · | -18.4 | · | · | |
| P / FCF | · | -73.6 | · | · | · | -32.9 | · | · | · | -26.3 | · | · | · | -18.4 | · | · | |
| EV / EBITDA | · | · | · | · | -55.8 | -58.4 | · | -26.0 | -27.1 | 2940.1 | · | -28.7 | -19.7 | -21.3 | · | · | |
| EV / FCF | · | · | · | · | · | -30.2 | · | · | · | -25.9 | · | · | · | -18.4 | · | · | |
| EV / Revenue | · | · | · | · | 32.3 | 18.1 | · | 22.6 | 21.7 | 26.1 | · | 573.5 | 37.2 | 34.2 | · | · | |
| Earnings Yield | -4.7% | -4.9% | · | -7.0% | -7.1% | -6.7% | · | -9.9% | -10.5% | -10.3% | · | -14.8% | -16.9% | -19.7% | · | -34.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $502M | $222M | $9M | $78M | $70M |
| 영업이익률 % | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% |
| 순이익 | $-733M | $-543M | $-653M | $-485M | $-586M |
| 희석 EPS | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | -0.3 | -0.3 | -0.3 | -0.5 |
| 유동비율 | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 |
| 당좌 비율 | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-447M | $-522M | $-529M | $-424M | $-511M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 532개의 제출자 · $11.5B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 98 (+4 이전 분기 대비) | 65 (+9 이전 분기 대비) | 176 (0 이전 분기 대비) | 161 (+14 이전 분기 대비) | +32.3M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $987,677,120 | 13,260,971 | 8.61% | 주식 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $800,143,332 | 10,743,063 | 6.97% | 주식 |
| VIKING GLOBAL INVESTORS LP | $741,017,831 | 9,949,219 | 6.46% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $588,315,509 | 7,898,973 | 5.13% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $570,272,655 | 7,656,722 | 4.97% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $360,280,689 | 4,837,281 | 3.14% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $351,708,339 | 4,722,185 | 3.06% | 주식 |
| Aisling Capital Management LP | $341,834,227 | 4,589,611 | 2.98% | 주식 |
| STATE STREET CORP | $330,388,215 | 4,435,932 | 2.88% | 주식 |
| UBS Group AG | $287,753,480 | 3,863,500 | 2.51% | 콜 옵션 |
| JANE STREET GROUP, LLC | $232,407,392 | 3,120,400 | 2.02% | 콜 옵션 |
| CITADEL ADVISORS LLC | $231,388,431 | 3,106,719 | 2.02% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $221,507,973 | 2,973,184 | 1.93% | 주식 |
| D. E. Shaw & Co., Inc. | $218,406,046 | 2,932,412 | 1.90% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195,152,496 | 2,620,200 | 1.70% | 콜 옵션 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $167,728,960 | 2,252,000 | 1.46% | 주식 |
| Polar Capital Holdings Plc | $153,697,598 | 2,063,609 | 1.34% | 주식 |
| FMR LLC | $152,985,495 | 2,054,048 | 1.33% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $145,662,994 | 1,955,733 | 1.27% | 주식 |
| SC US (TTGP), LTD. | $138,559,911 | 1,860,364 | 1.21% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127,311,718 | 1,709,341 | 1.11% | 주식 |
| NORGES BANK | $126,152,213 | 1,693,773 | 1.10% | 주식 |
| Frazier Life Sciences Management, L.P. | $115,305,393 | 1,548,139 | 1.00% | 주식 |
| Point72 Asset Management, L.P. | $113,640,243 | 1,525,782 | 0.99% | 주식 |
| JANE STREET GROUP, LLC | $112,904,828 | 1,515,908 | 0.98% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $107,937,207 | 1,453,504 | 0.94% | 주식 |
| Pictet Asset Management Holding SA | $107,362,071 | 1,448,126 | 0.94% | 주식 |
| TWO SIGMA ADVISERS, LP | $107,165,167 | 1,401,035 | 0.93% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $102,265,291 | 1,373,057 | 0.89% | 주식 |
| Laurion Capital Management LP | $100,714,388 | 1,352,234 | 0.88% | 주식 |
| Hood River Capital Management LLC | $100,364,407 | 1,347,535 | 0.87% | 주식 |
| Balyasny Asset Management L.P. | $91,614,273 | 1,230,052 | 0.80% | 주식 |
| Squarepoint Ops LLC | $88,760,199 | 1,191,732 | 0.77% | 주식 |
| VANGUARD GROUP INC | $88,444,087 | 1,156,283 | 0.77% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $86,057,320 | 1,155,442 | 0.75% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $83,193,341 | 1,116,989 | 0.72% | 주식 |
| AMERIPRISE FINANCIAL INC | $82,434,273 | 1,106,795 | 0.72% | 주식 |
| PRIMECAP MANAGEMENT CO/CA/ | $75,670,190 | 1,015,980 | 0.66% | 주식 |
| FIL Ltd | $74,648,325 | 1,002,260 | 0.65% | 주식 |
| Clearbridge Investments, LLC | $73,966,324 | 993,103 | 0.64% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73,400,040 | 985,500 | 0.64% | 풋 옵션 |
| GOLDMAN SACHS GROUP INC | $66,118,056 | 887,729 | 0.58% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $63,817,890 | 856,846 | 0.56% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $61,804,000 | 829,802 | 0.54% | 주식 |
| Ensign Peak Advisors, Inc | $56,677,567 | 760,977 | 0.49% | 주식 |
| Qube Research & Technologies Ltd | $54,162,228 | 727,205 | 0.47% | 주식 |
| Capital Research Global Investors | $52,143,969 | 700,107 | 0.45% | 주식 |
| BARCLAYS PLC | $51,071,756 | 685,711 | 0.44% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48,652,124 | 653,224 | 0.42% | 주식 |
| First Turn Management, LLC | $47,172,951 | 633,364 | 0.41% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $46,288,968 | 621,494 | 0.40% | 주식 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $46,261,390 | 621,125 | 0.40% | 주식 |
| BANK OF AMERICA CORP /DE/ | $41,878,465 | 562,278 | 0.36% | 주식 |
| Cormorant Asset Management, LP | $40,964,000 | 550,000 | 0.36% | 주식 |
| GILDER GAGNON HOWE & CO LLC | $40,884,008 | 548,926 | 0.36% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $36,316,001 | 487,594 | 0.32% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $35,176,457 | 472,294 | 0.31% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $34,092,848 | 457,745 | 0.30% | 주식 |
| Catalio Capital Management, LP | $33,891,454 | 455,041 | 0.30% | 주식 |
| Bridgewater Associates, LP | $33,377,691 | 448,143 | 0.29% | 주식 |
| EVENTIDE ASSET MANAGEMENT, LLC | $32,557,442 | 437,130 | 0.28% | 주식 |
| Fisher Asset Management, LLC | $25,721,741 | 345,351 | 0.22% | 주식 |
| UBS Group AG | $25,687,705 | 344,894 | 0.22% | 주식 |
| BOONE CAPITAL MANAGEMENT LLC | $25,302,346 | 339,720 | 0.22% | 주식 |
| NOMURA HOLDINGS INC | $24,390,338 | 327,475 | 0.21% | 주식 |
| Weiss Asset Management LP | $23,847,304 | 320,184 | 0.21% | 주식 |
| Nicholas Investment Partners, LP | $23,200,073 | 311,494 | 0.20% | 주식 |
| Woodline Partners LP | $22,441,718 | 301,312 | 0.20% | 주식 |
| Candriam S.C.A. | $22,361,195 | 300,520 | 0.19% | 주식 |
| MACKENZIE FINANCIAL CORP | $22,227,811 | 298,440 | 0.19% | 주식 |
| Swiss National Bank | $21,941,808 | 294,600 | 0.19% | 주식 |
| CITADEL ADVISORS LLC | $21,278,936 | 285,700 | 0.19% | 콜 옵션 |
| CITADEL ADVISORS LLC | $20,943,776 | 281,200 | 0.18% | 풋 옵션 |
| Integral Health Asset Management, LLC | $20,482,000 | 275,000 | 0.18% | 주식 |
| NOMURA HOLDINGS INC | $19,811,680 | 266,000 | 0.17% | 콜 옵션 |
| PFM Health Sciences, LP | $18,870,104 | 253,358 | 0.16% | 주식 |
| FIRST TRUST ADVISORS LP | $18,451,526 | 247,738 | 0.16% | 주식 |
| SPHERA FUNDS MANAGEMENT LTD. | $18,273,370 | 245,346 | 0.16% | 주식 |
| MARSHALL WACE, LLP | $17,913,781 | 240,518 | 0.16% | 주식 |
| Caption Management, LLC | $17,726,240 | 238,000 | 0.15% | 콜 옵션 |
| Susquehanna Portfolio Strategies, LLC | $16,897,203 | 226,869 | 0.15% | 주식 |
| ExodusPoint Capital Management, LP | $16,752,563 | 224,927 | 0.15% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $16,565,618 | 222,417 | 0.14% | 주식 |
| NAN FUNG TRINITY (HK) LTD | $16,327,133 | 219,215 | 0.14% | 주식 |
| ROYCE & ASSOCIATES LP | $16,272,912 | 218,487 | 0.14% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $15,553,137 | 208,823 | 0.14% | 주식 |
| ALGERT GLOBAL LLC | $15,305,417 | 205,497 | 0.13% | 주식 |
| CITIGROUP INC | $14,598,080 | 196,000 | 0.13% | 풋 옵션 |
| California Public Employees Retirement System | $14,514,067 | 194,872 | 0.13% | 주식 |
| Longaeva Partners L.P. | $13,992,036 | 187,863 | 0.12% | 주식 |
| MIZUHO MARKETS AMERICAS LLC | $13,585,748 | 182,408 | 0.12% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $13,570,256 | 182,200 | 0.12% | 콜 옵션 |
| Cutter Capital Management, LP | $13,504,563 | 390,644 | 0.12% | 주식 |
| ADAR1 Capital Management, LLC | $13,159,797 | 176,689 | 0.11% | 주식 |
| BlackRock, Inc. | $12,997,803 | 174,514 | 0.11% | 주식 |
| RHUMBLINE ADVISERS | $12,750,043 | 171,188 | 0.11% | 주식 |
| ROYAL BANK OF CANADA | $12,654,000 | 169,892 | 0.11% | 주식 |
| Hillsdale Investment Management Inc. | $12,595,462 | 169,112 | 0.11% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12,305,105 | 165,703 | 0.11% | 주식 |
| WCM INVESTMENT MANAGEMENT, LLC | $11,891,227 | 165,133 | 0.10% | 주식 |
회사 내부자 25 명의 내부자 · 9 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Neil Kumar | Chief Executive Officer | 2026년 8월 16일 M | 278,307 | 0 | 4 | $-1,573,882 |
| Thomas Trimarchi | President and CFO | 2026년 8월 16일 F | 336,529 | 0 | 3 | $-2,961,545 |
| Brian C Stephenson | CFO and Treasurer | 2025년 2월 25일 M | 102,464 | 0 | 0 | $0 |
| Brian M. Stolz | Chief Operating Officer | 2020년 8월 16일 M | 24,615 | 0 | 0 | $0 |
| Maricel Apuli | Chief Accounting Officer | 2026년 8월 16일 F | 122,687 | 0 | 1 | $-160,120 |
| Cameron Turtle | Senior Vice President, Portfolio Management and Corporate Development | 2020년 12월 28일 M | 12,568 | 0 | 0 | $0 |
| Michael Thomas Henderson | Chief Business Officer | 2020년 12월 15일 A | 274,211 | 0 | 0 | $0 |
| Uma Sinha | Chief Scientific Officer | 2020년 12월 15일 A | 16,460 | 0 | 0 | $0 |
| Yi Ching Yau | Chief Accounting Officer | 2020년 11월 16일 M | 4,586 | 0 | 0 | $0 |
| Andrea Ellis | 이사 | 2026년 7월 9일 M | 22,579 | 0 | 1 | $-1,442,028 |
| Jennifer E. Cook | 이사 | 2026년 7월 9일 M | 8,383 | 0 | 6 | $-21,920,848 |
| Hannah Valantine | 이사 | 2026년 6월 22일 M | 9,259 | 0 | 2 | $-341,524 |
| Andrew Lo | 이사 | 2026년 6월 22일 A | 18,079 | 0 | 0 | $0 |
| Douglas A. Dachille | 이사 | 2026년 6월 22일 A | 10,579 | 0 | 0 | $0 |
| Ali J. Satvat | 이사 | 2026년 6월 22일 A | 169,983 | 0 | 0 | $0 |
| Eric Aguiar | 이사 | 2026년 6월 22일 A | 10,579 | 0 | 0 | $0 |
| Frank Mccormick | 이사 | 2026년 6월 22일 A | 10,579 | 0 | 1 | $-3,933,840 |
| James C Momtazee | 이사 | 2026년 6월 22일 A | 19,070 | 0 | 0 | $0 |
| Charles J Homcy | 이사 | 2026년 6월 22일 A | 919,876 | 0 | 0 | $0 |
| DANIELS RONALD J | 이사 | 2026년 6월 22일 A | 20,981 | 0 | 0 | $0 |
| Fred Hassan | 이사 | 2026년 6월 22일 A | 29,879 | 0 | 0 | $0 |
| Randal W Scott | 이사 | 2025년 6월 20일 A | 11,589 | 0 | 0 | $0 |
| Richard H Scheller | 이사 | 2023년 2월 16일 M | 53,822 | 0 | 0 | $0 |
| Brent L Saunders | 이사 | 2022년 6월 22일 A | 17,600 | 0 | 0 | $0 |
| BridgeBio Pharma, Inc. | 10% 소유주 | 2021년 1월 26일 P | 1,000 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| KKR Genetic Disorder L.P., KKR Genetic Disorder GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×8 제출 서류 | 2026년 8월 17일 | 4.70% | 수정본 | 자본 구조 | SEC |
| VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Shabet Rose Sharon ×13 제출 서류 | 2026년 7월 10일 | 5.00% | 수정본 | — | SEC |
| BridgeBio Pharma, Inc. ×6 제출 서류 | 2021년 1월 26일 | — | 최초 제출 | M&A / 매각 | SEC |
| Eidos Therapeutics, Inc. ×2 제출 서류 | 2021년 1월 26일 | — | 최초 제출 | — | SEC |
| BridgeBio Pharma LLC ×4 제출 서류 | 2018년 12월 13일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 78 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 2.75% | 73,191 NS | 2026년 5월 31일 | N-PORT |
| HRTS · Tema ETF Trust | 2.59% | 20,327 NS | 2026년 5월 31일 | N-PORT |
| BBP · ETFis Series Trust I | 1.51% | 12,592 NS | 2026년 4월 30일 | N-PORT |
| SPIT · RBB Fund, Inc. | 1.37% | 5,527 NS | 2026년 4월 30일 | N-PORT |
| LFSC · RBB Fund, Inc. | 1.17% | 18,534 NS | 2026년 5월 31일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.13% | 10,659 SH | 2026년 8월 8일 | 일간 |
| JSML · Janus Detroit Street Trust | 1.11% | 49,222 NS | 2026년 4월 30일 | N-PORT |
| IBB · iShares Trust | 1.08% | 1,241,499 SH | 2026년 8월 8일 | 일간 |
| JSMD · Janus Detroit Street Trust | 1.06% | 145,924 NS | 2026년 4월 30일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.93% | 68,003 NS | 2026년 4월 30일 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund VI… | 0.82% | 35,282 NS | 2026년 5월 31일 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0.80% | 111,721 SH | 2026년 8월 8일 | 일간 |
| GSC · Goldman Sachs ETF Trust | 0.73% | 27,974 NS | 2026년 5월 31일 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0.73% | 2,214 NS | 2026년 5월 31일 | N-PORT |
| BIB · ProShares Trust | 0.64% | 7,167 NS | 2026년 5월 31일 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.62% | 3,028 NS | 2026년 5월 31일 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.58% | 69,186 NS | 2026년 4월 30일 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.51% | 36,933 NS | 2026년 4월 30일 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.49% | 20,355 NS | 2026년 5월 31일 | N-PORT |
| ISCG · iShares Trust | 0.43% | 51,606 SH | 2026년 8월 8일 | 일간 |
| IQSM · New York Life Investments ETF Trust | 0.41% | 18,338 NS | 2026년 4월 30일 | N-PORT |
| IWP · iShares Trust | 0.38% | 923,082 SH | 2026년 8월 8일 | 일간 |
| SMLF · iShares Trust | 0.36% | 186,284 SH | 2026년 8월 8일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | 0.36% | 2,334,646 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.34% | 68,833 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.26% | 7,470 NS | 2026년 5월 31일 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.26% | 49,007 NS | 2026년 4월 30일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.24% | 815,199 NS | 2026년 5월 31일 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.23% | 20,342 NS | 2026년 4월 30일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.23% | 77,319 NS | 2026년 4월 30일 | N-PORT |
| IYH · iShares Trust | 0.23% | 101,091 SH | 2026년 8월 8일 | 일간 |
| ISCB · iShares Trust | 0.21% | 7,345 SH | 2026년 8월 8일 | 일간 |
| FTLS · First Trust Exchange-Traded Fund III | 0.21% | 68,022 NS | 2026년 4월 30일 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.21% | 459,045 NS | 2026년 5월 31일 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.20% | 56,781 NS | 2026년 4월 30일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.19% | 28,343 NS | 2026년 5월 31일 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.19% | 50,525 SH | 2026년 8월 8일 | 일간 |
| SMMD · iShares Trust | 0.19% | 84,760 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 66,688 NS | 2026년 4월 30일 | N-PORT |
| ESML · iShares Trust | 0.17% | 57,771 SH | 2026년 8월 8일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.16% | 4,042,835 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.16% | 441,129 SH | 2026년 8월 8일 | 일간 |
| UWM · ProShares Trust | 0.16% | 5,841 NS | 2026년 5월 31일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 10,157 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.14% | 1,977,374 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.14% | 46,316 SH | 2026년 8월 8일 | 일간 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.12% | 179 NS | 2026년 5월 31일 | N-PORT |
| WSML · iShares Trust | 0.11% | 9,054 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.11% | 5,909 NS | 2026년 5월 31일 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.11% | 11,025 SH | 2026년 8월 8일 | 일간 |